Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
July 13, 2022 by eurekalert.org
Switching from tobacco to e-cigarettes does not reverse respiratory epithelium damage
Some studies have suggested electronic cigarette, or EC, use may be a healthier alternative to cigarette smoking. A University of California, Riverside, study shows this is far from the case.
The researchers report in the journal Toxics that switching from combustible cigarettes to ECs does not restore the nasal epithelium to that of a non-smoker. Specifically, the researchers found the epithelium gene expression profiles of EC users do not revert to the typical epithelium gene expression profiles of non-smokers.
“Indeed, compared to non-smokers, the EC group showed molecular alterations in their gene expression profiles that are associated with cigarette smokers,” said Giovanna Pozuelos, [...]
July 12, 2022 by filtermag.org
The FDA’s Unconscionable Campaign to Destroy Juul
Shock and disbelief. That’s what ripped through the tobacco harm reduction community when the US Food and Drug Administration (FDA) ordered Juul e-cigarettes off the market on June 23. The reason? After examining $100 million worth of scientific submissions, and with certain knowledge that millions of people have used Juul vapes for years—mostly to replace deadly cigarettes—with no significant demonstrated adverse health effects, the agency claimed, “there is insufficient evidence to assess the potential toxicological risks of using JUUL products” and that they are not “appropriate for the protection of public health.”
July 11, 2022 by filtermag.org
FDA Backs Away From Its Own Juul Decision With “Additional Review”
On July 5, just two weeks after the Food and Drug Administration (FDA) ordered Juul to pull its products off the US market, the agency walked back on its decision, issuing an administrative stay on its own marketing denial order (MDO). In a puzzling series of events, the FDA acknowledged to Filter that it is “temporarily suspending the marketing denial order pending additional review,” though not rescinding it. And this seems to be on the basis of legal documents that Juul immediately filed in response to the decision.
July 01, 2022 by theconversation.com
The FDA and Juul are fighting over a vape ban, but the role of e-cigarettes in the world of tobacco abuse is not clear-cut
According to the FDA, the decision was a precautionary response due to a lack of “sufficient evidence regarding the toxicological profile of the products” to ensure protection of public health. The FDA also noted that it hadn’t received any information suggesting Juul products were an “immediate hazard.”
In the announcement, FDA commissioner Robert M. Califf commented on the effects Juul products have had on youth vaping. And this decision comes at a time when some have hoped that a new ban on Juul products and other e-cigarettes for adults would help reduce vaping by teens.
July 01, 2022 by unchealthcare.org
Fourth-generation Vaping Devices Increase Risk to Immune Cells
Not all electronic cigarette devices are created equal. Some fourth-generation models – such as Juul devices – are associated with unique changes in markers of immune responses inside our airways, according to a new peer-reviewed paper from UNC School of Medicine researchers led by toxicologist Ilona Jaspers, [...]
Lead author Elise Hickman, PhD, a recent graduate from Jaspers’ lab, and colleagues, who published their research in the American Journal of Respiratory and Critical Care Medicine, found that users of fourth-generation nicotine-salt-containing devices display a unique mix of cellular biomarkers indicative of immune suppression.
June 28, 2022 by regulatorwatch.com
Juul Ban | Consumer Impact & Industry Future | RegWatch
Since nicotine vapes first hit the market in 2007, the United States has been the lead driver of innovation and consumer adoption of these products, worldwide.
But while the U.S. is still the largest market for vaping products, anti-vaping zealotry and regulatory insolence has all but destroyed the legal U.S. vaping industry. Case-in-point FDA’s recent ban on Juul.
Joining us today for a deep dive into the impact of FDA’s Juul ban and to discuss how the War on Vaping harms consumers is Alex Clark, CEO of CASAA, the national consumer advocacy organization for smoke-free alternatives.
June 28, 2022 by saltwire.com
Juul ban could allow Altria to explore e-cigarette options - analysts
Juul's U.S. e-cigarette ban could pave the way for Altria, one of its largest investors, to pursue other vaping product makers or go it alone, Wall Street analysts said on Friday.
Despite regulators highlighting the risks of vaping, analysts say e-cigarettes are key to the nicotine industry's future, with JP Morgan analysts expecting the $11-billion U.S. retail market to double in size by 2030.
Altria, like other tobacco majors, has therefore been investing in smokeless options, including snus and snuff, amid a broader crackdown on the use of cigarettes due to health risks.
June 27, 2022 by nytimes.com
Juul Gets Temporary Reprieve to Keep Selling Its E-Cigarettes
A federal appeals court on Friday granted a temporary reprieve to Juul Labs that will allow it to keep its e-cigarettes on the market, pending further court review of a decision just a day earlier by the Food and Drug Administration to ban sales of the company’s products.
The United States Court of Appeals for the District of Columbia issued a temporary stay that had been sought by Juul. The brief order by the appeals court cautioned that the stay was “ should not be construed in any way as a ruling on the merits.”
June 23, 2022 by filtermag.org
Juul to Be Removed From US Vape Market by the FDA, Reports Say
The FDA is planning to deny the marketing applications for Juul, reports The Wall Street Journal, which would pull one of the most popular e-cigarettes off the US market.
Filter has been unable to independently confirm the news. The FDA has not responded to request for comment, and so far offered no reason for the alleged denial. Juul also did not respond to a request for comment by publication time. Mitch Zeller, the former director of the Food and Drug Administration’s Center for Tobacco Products (CTP), declined to comment over email.
June 23, 2022 by medscape.com
AHA Urges Immediate Action to Curb Vaping Among Youth
Action is needed now to reduce or prevent adolescents from accessing and using electronic cigarettes, the American Heart Association (AHA) concludes in a new scientific statement. Current scientific evidence indicates that use of these vaping products has harmful effects on health that can accrue over time, leading to an increased risk for cardiovascular and pulmonary disease in long-term users, the writing group says. "Inhaling any foreign substance can have effects on the respiratory and cardiovascular systems," writing group chair Loren E. Wold, PhD, Ohio State University College of Medicine, Columbus, says in an AHA news release.